Sector: Pharmaceuticals & Biotechnology

Mid Cap

Supriya Lifescience Share Price

Supriya Lifescience Ltd.

₹766.50

-7.60(-0.98%)

Invest in SUPRIYA with up to 2.22x margin.

Trade with MTF

25th May 2026 | 2:58 PM

NSE : SUPRIYA

Open Free Demat Account

Supriya Lifescience Performance

Price Movement

₹766.50

₹763.00

₹787.00

↘ Today's Low↗ Today's High

1 Year Performance

₹766.50

₹545.50

₹832.40

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹787.00

Low₹763.00

Open at₹775.80

Prev Close₹774.10

Volumes1.81 L

Avg Price₹776.28

Lower Circuit₹619.30

Upper Circuit₹928.90

Historical Performance

3M High₹735.95

3M Low₹545.50

1 Yr High₹832.40

1 Yr Low₹545.50

3 Yr High₹842.00

3 Yr Low₹233.30

5 Yr High₹842.00

5 Yr Low₹170.15

Supriya Lifescience Fundamentals

Market Cap

Above industry Median

5,837 Cr.

PE Ratio (TTM)

Above industry Median

31.50

Dividend Yield

Low in industry

0.10

Net Profit TTM

6.2% incr over last year

185.27

Net Profit Growth

6.2% incr over last year

185.27

PEG Ratio

High in industry

5.10

ROE

29.1% incr over last year

18.85

Operating Revenue TTM

735.46

Operating Revenue Growth

9.7% incr over last year

Book Value

Above industry Median

5.20

MFI

MFI is mid-range

RSI

RSI is mid-range

63.50

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

5.20

Supriya Lifescience Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	206.44	199.83	145.07	184.11	185.65
Operating Expense	134.36	127.19	93.37	116.52	119.70
Operating Profit	72.08	72.65	51.70	67.58	65.95
Depreciation	6.82	6.64	6.45	6.08	4.96
Interest	0.49	0.42	0.51	0.42	0.51
Tax	17.24	17.89	12.62	13.68	15.80
Net Profit	49.68	50.43	34.79	50.38	46.78

Supriya Lifescience Technicals

Supriya Lifescience Ltd. EMA & SMA

₹766.50

45.90 (6.37%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹698.6

Day EMA10 ₹694.1

Day EMA12 ₹692.1

Day EMA20 ₹682.5

Day EMA26 ₹676

Day EMA50 ₹664.8

Day EMA100 ₹670.6

Day EMA200 ₹677.8

Supriya Lifescience Support and Resistance

Resistance

First Resistance₹741.13

Second Resistance₹761.67

Third Resistance₹787.38

Support

First Support₹694.88

Second Support₹669.17

Third Support₹648.63

Technical Indicators

Day RSI63.50

Day MFI65.00

Day ADX25.41

Day Commodity Channel Index110.00

William-21.94

Day MACD16.07

Day MACD Signal Line17.29

Day ATR27.64

Day ROC125-8.40

Day ROC2112.86

Supriya Lifescience Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	68.3	68.3	68.3	68.3	68.3	68.3
FII	6.5	7.2	6.8	5.5	5.2	5.2
DII	4.9	4.2	4.8	5.2	5	5.7
Public	20.2	20.2	20.1	21	21.5	20.8

Supriya Lifescience Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	1.94 L	6.19 L	31.40%
Week	86.48 K	2.11 L	40.95%
1 Month	1.3 L	2.71 L	47.86%
6 Month	91.03 K	1.74 L	52.22%

Supriya Lifescience SWOT Analysis

Strengths21

Weakness3

Opportunity2

Threats2

Companies with no Debt

Benjamin Graham Value Screen

Price crossing above SMA20 today, and greater than SMA5

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

Stocks gaining versus previous close, open price and RSI

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Increasing Revenue every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Top Gainers

Supriya Lifescience Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
04 Sep, 2025	1	FINAL	05 Sep, 2025	Equity Share
20 Sep, 2024	0.8	FINAL		Equity Share
15 Sep, 2023	0.6	FINAL		Equity Share
01 Sep, 2022	0.6	FINAL		Equity Share

Supriya Lifescience Stock Comparison

Financials	Corona Remedies Ltd.	Rubicon Research Ltd.	Senores Pharmaceuticals Ltd.	Sanofi Consumer Healthcare India Ltd.	Blue Jet Healthcare Ltd	Concord Biotech Ltd.
Price (₹)	₹1,700	₹944.95	₹1,148.50	₹4,640	₹481.10	₹1,132.80
% Change	0.91%	-0.51%	3.38%	-2.01%	9.08%	-1.78%
Revenue TTM (₹ Cr)	₹1,403.18	₹1,598.19	₹649.50	₹935	₹1,053.10	₹1,158.69
Net Profit TTM (₹ Cr)	₹185.12	₹206.20	₹115.38	₹257.90	₹293.57	₹312.50
PE TTM	57.20	78.90	43.30	43.40	25.90	37.40
1 Year Return	63.07	103.31	111.14	-2.21	-46.56	-26.82
ROCE	31.54	34.76	15.60	-	52.32	26.82

Similar Stocks

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 729.90

+2.36%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1051.90

+1.24%

COHANCE

Cohance Lifesciences Ltd.

₹ 433.70

+3.62%

ERIS

Eris Lifesciences Ltd.

₹ 1352.80

+0.67%

SYNGENE

Syngene International Ltd.

₹ 463.70

+0.40%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 229.25

+9.29%

STAR

Strides Pharma Science Ltd.

₹ 1191.30

+3.30%

GRANULES

Granules India Ltd.

₹ 758.90

+0.92%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 1005.60

-0.07%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 2082.40

+2.68%

SANOFI

Sanofi India Ltd.

₹ 3186.80

+0.75%

PGHL

Procter & Gamble Health Ltd.

₹ 5698.00

+2.61%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 633.75

-2.46%

FAQ's on SUPRIYA

What is the current share price of Supriya Lifescience Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Supriya Lifescience Ltd. is ₹ 766.5 on the NSE and ₹ 766.75 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Supriya Lifescience Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Supriya Lifescience Ltd. is approximately ₹ 5837 Cr.

What are the PE and PB ratios for Supriya Lifescience Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Supriya Lifescience Ltd. is 31.5, and the Price-to-Book (PB) ratio is 5.2.

What is the 52-Week High and Low for Supriya Lifescience Ltd.?

Over the past 52 weeks, the highest price reached by Supriya Lifescience Ltd. shares was ₹ 832.4, and the lowest price was ₹ 545.5.

What is the current dividend yield for Supriya Lifescience Ltd.?

As of 6 June 2025, the dividend yield for Supriya Lifescience Ltd. is 0.1%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Supriya Lifescience Ltd.?

Significant shareholdings in Supriya Lifescience Ltd. typically include entities such as:

Promoter
Public
FII
Other Institutions
Mutual Funds

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Supriya Lifescience Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Supriya Lifescience Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

What is the latest dividend information for Supriya Lifescience Ltd.?

Supriya Lifescience Ltd. last declared a FINAL dividend of ₹ 1 per share for the financial period ending 2025. The record date was set as 2025-09-04, and the payment was/is scheduled around 2025-09-04. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy